Zoetis Inc - Class A
Research Zoetis Inc - Class A (ZTS) on Bullrun: valuation model: 47.3% undervalued, market cap USD 30.98B, P/E 12.3, dividend yield 2.8%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerZTS
- ExchangeNYSE
- CountryUnited States
- SectorHealthcare
- IndustryDrug Manufacturers-Specialty & Generic
- CurrencyUSD
- Valuation signal47.3% undervalued
- Market capUSD 30.98B
- P/E12.3
- Dividend yield2.8%
- Financial periodQ2 2026
- RevenueUSD 2.47B
- Net incomeUSD 691.00M
- Free cash flowUSD 538.00M
- Gross margin72.7%
Valuation Snapshot
Bullrun's latest valuation model marks Zoetis Inc - Class A as 47.3% undervalued; latest market cap is USD 30.98B; P/E is 12.3; dividend yield is 2.8%.
Peer valuation comparison
Latest P/E is 12.31x versus a Healthcare sector median of 24.61x (50.0% below).
Latest dividend yield is 2.76% versus a Healthcare sector median of 1.84% (50.0% above).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 9.47B | USD 2.67B | USD 2.28B | 71.8% | 6.02 | USD 2.45B | USD 9.04B | USD 3.42B |
| FY2024 | USD 9.26B | USD 2.49B | USD 2.30B | 70.6% | 5.47 | USD 1.99B | USD 6.57B | USD 4.77B |
| FY2023 | USD 8.54B | USD 2.34B | USD 1.62B | 70.0% | 5.07 | USD 2.04B | USD 6.56B | USD 5.00B |
| FY2022 | USD 8.08B | USD 2.11B | USD 1.33B | 69.6% | 4.49 | USD 3.58B | USD 7.90B | USD 4.41B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-09 | USD 30.98B | 12.3 | 2.8% | 2.09 |
| 2025 | 2025-12-31 | USD 53.46B | 20.9 | 1.6% | 2 |
| 2024 | 2024-12-31 | USD 73.07B | 29.8 | 1.1% | 1.72 |
| 2023 | 2023-12-29 | USD 90.62B | 40.1 | 0.8% | 1.52 |
| 2022 | 2022-12-30 | USD 68.30B | 33.5 | 0.9% | 1.32 |
| 2021 | 2021-12-31 | USD 115.32B | 57.1 | 0.4% | 1 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 2.09 USD, yield 2.8%.
| Year | Dividends/share |
|---|---|
| FY2025 | 2.03 USD |
| FY2024 | 1.8 USD |
| FY2023 | 1.56 USD |
| FY2022 | 1.35 USD |
About Zoetis Inc - Class A
Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health solutions for the animal health industry in the United States and internationally. The company commercializes products primarily across companion animals comprising dogs, cats, and horses; and species, including livestock, such as cattle, swine, poultry, fish, and sheep.
ETFs that hold Zoetis Inc - Class A
Zoetis Inc - Class A is one of the ten largest holdings of 2 ETFs that investors in Europe can buy, most traded first:
| ETF | Weight | TER |
|---|---|---|
| VanEck Agribusiness UCITS ETF A USD | 5.65% | 0.55% |
| BNP Paribas Easy MSCI USA SRI S-Series PAB 5% Capped | 2.04% | 0.25% |
Related stock research
Other Healthcare stocks
Frequently asked questions
Is Zoetis Inc - Class A overvalued or undervalued?
Bullrun's valuation model currently marks Zoetis Inc - Class A as 47.3% undervalued.
What is Zoetis Inc - Class A's market cap?
Zoetis Inc - Class A's market capitalization is USD 30.98B.
What is Zoetis Inc - Class A's P/E ratio?
Zoetis Inc - Class A's price-to-earnings (P/E) ratio is 12.3.
Does Zoetis Inc - Class A pay a dividend?
Zoetis Inc - Class A has a dividend yield of 2.8%.
What does Zoetis Inc - Class A do?
Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health solutions for the animal health industry in the United States and internationally. The company commercializes products primarily across companion animals comprising dogs, cats, and horses; and species, including livestock, such as cattle, swine, poultry, fish, and sheep.